IVA · Nasdaq, OTC · CIK 0001756594
Inventiva S.A.
Inventiva S.A.’s most recent SEC filing in our snapshot is a Form SCHEDULE 13G/A filed on Oct 27, 2026. In fiscal 2024 (year ended Dec 31, 2024) it reported revenue of EUR 9.2M and net income of -EUR 184.2M, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Inventiva S.A.
- Tickers
- IVA, IVEVF
- SEC Central Index Key (CIK)
- 0001756594
- Industry (SIC)
- Pharmaceutical Preparations (code 2834)
- Business address
- DAIX, France
- State or country of incorporation
- France
- Fiscal year ends
- December 31
- SEC filer category
- Accelerated filer
- Position in SEC ticker list
- #2532 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Inventiva S.A.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in EUR; the fiscal year is named for the calendar year in which it ends.
| Item | FY2020 ended Dec 31, 2020 | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 |
|---|---|---|---|---|---|
| Revenue | EUR 372.0K | EUR 4.2M | EUR 12.2M | EUR 17.5M | EUR 9.2M |
| Net income | -EUR 33.6M | -EUR 49.6M | -EUR 54.3M | -EUR 110.4M | -EUR 184.2M |
| Diluted EPS | -EUR 0.99 | -EUR 1.27 | -EUR 1.31 | -EUR 2.43 | -EUR 3.08 |
| Total assets | EUR 138.9M | EUR 122.0M | EUR 116.0M | EUR 69.6M | EUR 119.0M |
| Cash and equivalents | EUR 93.7M | EUR 43.7M | EUR 69.9M | EUR 9.0M | EUR 25.9M |
XBRL tags used: revenue = Revenue; netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = Cash. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
Recent SEC filings
The 40 newest documents filed by or about Inventiva S.A., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 27, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Oct 6, 2026 | 6-K | Report of a foreign private issuer· period Oct 6, 2026 | Document · Index |
| Sep 28, 2026 | 6-K | Report of a foreign private issuer· period Jun 30, 2026 | Document · Index |
| Sep 3, 2026 | 6-K | Report of a foreign private issuer· period Sep 2, 2026 | Document · Index |
| Sep 1, 2026 | 6-K | Report of a foreign private issuer· period Aug 31, 2026 | Document · Index |
| Jul 30, 2026 | 6-K/A | 6-K/A· period Jul 30, 2026 | Document · Index |
| Jul 29, 2026 | 6-K | Report of a foreign private issuer· period Jul 29, 2026 | Document · Index |
| Jul 9, 2026 | 6-K | Report of a foreign private issuer· period Jul 9, 2026 | Document · Index |
| Jul 6, 2026 | 6-K | Report of a foreign private issuer· period Jul 2, 2026 | Document · Index |
| Jun 12, 2026 | 6-K | Report of a foreign private issuer· period Jun 12, 2026 | Document · Index |
| Jun 12, 2026 | 6-K | Report of a foreign private issuer· period Jun 12, 2026 | Document · Index |
| Jun 9, 2026 | 6-K | Report of a foreign private issuer· period Jun 9, 2026 | Document · Index |
| Jun 3, 2026 | 6-K | Report of a foreign private issuer· period Jun 3, 2026 | Document · Index |
| Jun 3, 2026 | 6-K | Report of a foreign private issuer· period Jun 2, 2026 | Document · Index |
| Jun 2, 2026 | 424B5 | 424B5 | Document · Index |
| Jun 2, 2026 | FWP | FWP | Document · Index |
| Jun 2, 2026 | F-3ASR | F-3ASR | Document · Index |
| May 26, 2026 | 6-K | Report of a foreign private issuer· period May 26, 2026 | Document · Index |
| May 22, 2026 | 6-K | Report of a foreign private issuer· period May 22, 2026 | Document · Index |
| May 15, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Apr 22, 2026 | 6-K | Report of a foreign private issuer· period Apr 22, 2026 | Document · Index |
| Apr 8, 2026 | 20-F | Annual report of a foreign private issuer· period Dec 31, 2025 | Document · Index |
| Apr 1, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Mar 30, 2026 | 6-K | Report of a foreign private issuer· period Mar 30, 2026 | Document · Index |
| Feb 17, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 17, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 17, 2026 | 6-K | Report of a foreign private issuer· period Feb 17, 2026 | Document · Index |
| Feb 17, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Feb 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Jan 30, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Nov 28, 2025 | 6-K | Report of a foreign private issuer· period Nov 28, 2025 | Document · Index |
| Nov 24, 2025 | 6-K | Report of a foreign private issuer· period Nov 21, 2025 | Document · Index |
| Nov 19, 2025 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Nov 19, 2025 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Nov 17, 2025 | 6-K | Report of a foreign private issuer· period Nov 17, 2025 | Document · Index |
| Nov 14, 2025 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Nov 14, 2025 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Nov 13, 2025 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Nov 13, 2025 | 6-K | Report of a foreign private issuer· period Nov 13, 2025 | Document · Index |
| Nov 13, 2025 | 424B5 | 424B5 | Document · Index |
Insider filing activity
0 Form 4 filings appear in Inventiva S.A.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Pharmaceutical Preparations
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001756594 and XBRL company facts. Inventiva S.A. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement